Frontotemporal dementia (FTD) is a neurodegenerative disorder mainly affecting the frontal and/or temporal lobes, leading to dementia with prominent behavioural and/or language disturbances. Symptom onset is most often between 45 and 65 years. Continue reading “Diagnostic Criteria for Behavioural Variant Frontotemporal Dementia”
The National Institute on Aging and the Alzheimer’s Association (NIA-AA) charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer’s disease (AD), referred to in this article as mild cognitive impairment due to AD. Continue reading “Revised Criteria for Diagnosis of Alzheimer’s Disease (AD)”
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these.
Continue reading “Revised Criteria for the Clinical Diagnosis of Dementia with Lewy Bodies (DLB)”
The Hachinski ischemic score (HIS) is known to be a simple clinical tool, currently used for differentiating major types of dementia, such as primary degenerative, vascular or multi-infarct, and mixed type.
Continue reading “Hachinski Ischemic Scale (HIS)”
Synucleinopathies, with and without dementia, encompass a wide range of diseases including Parkinson’s disease, multiple system atrophy, rapid eye movement (REM) sleep behavior disorder, and dementia with Lewy bodies (DLB). DLB is a neurodegenerative disorder resulting in slowly progressive and unrelenting dementia until death.
Continue reading “Diagnostic Criteria for Dementia with Lewy Bodies (DLB)”